Table 1.

Summary findings

		Prevalence effect size (adjusted odds ratio)		Cumulative incidence effect size (adjusted IRR)		Monthly incidence effect size, all rounds (adjusted differences in differences IRR)
		After rounds 1 and 2	After rounds 3 and 4	After rounds 1 and 2 (rainy season)	After rounds 3 and 4 (rainy season)	After rounds 1 and 2	After rounds 3 and 4
Low transmission	MDA	0.13 (0.02–0.92)*	0.53 (0.08–3.36)	0.23 (0.03–1.82)	0.40 (0.05–3.23)	0.59 (0.44–0.78)*	0.71 (0.49–1.04)
	fMDA	0.57 (0.13–2.50)	2.60 (0.57–11.83)	1.53 (0.31–7.59)	0.66 (0.09–4.94)	0.90 (0.70–1.15)	1.08 (0.77–1.52)
High transmission	MDA	0.86 (0.25–3.04)	1.31 (0.49–3.49)	0.34 (0.13–0.89)*	0.80 (0.26–2.42)	0.92 (0.73–1.15)	1.03 (0.72–1.47)
	fMDA	1.28 (0.36–4.60)	1.13 (0.40–3.19)	0.50 (0.19–1.35)	0.96 (0.31–3.00)	1.00 (0.80–1.25)	1.20 (0.84–1.70)

fMDA = focal MDA; MDA = mass drug administration.